press releases press releases SMURF-Therapeutics, Inc. DEC 21st, 2023 Poster Presentation at Annual AACR DEC 21st, 2023 Appointments to Leadership Team at Smurf Therapeutics DEC 21st, 2023 Publication of Smurf's Interaction with HIF DEC 21st, 2023 Poster Presentation at Annual AACR PRESS RELEASES Dr. Emile Youssef appointed Chief Medical Officer at SMURF-Therapeutics, Inc.Jan292024Time: 12:00 amDownload PDF SMURF-Therapeutics, Inc. Announces Six New Appointments to Scientific Advisory BoardDec12023Time: 12:00 am - 12:00 amDownload PDF EVENTS & PRESENTATIONS Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance.Jul182023Time: 12:00 am - 12:00 amDownload PDFSMURF-2 data in 2023 AACR Poster PresentationApr152023Time: 12:00 am - 12:00 amDownload PDF IN THE NEWS SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation: Molecular CellDec72023Time: 12:00 am - 12:00 amRead More Click Here For News Archives
